NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $317,255 | +14.6% | 551,556 | +40.1% | 0.04% | +8.6% |
| Q1 2023 | $276,766 | +16.1% | 393,749 | +273.2% | 0.04% | +12.9% |
| Q4 2022 | $238,427 | +15.2% | 105,499 | +62.9% | 0.03% | +6.9% |
| Q3 2022 | $207,000 | -2.4% | 64,771 | +15.9% | 0.03% | +3.6% |
| Q2 2022 | $212,000 | -10.5% | 55,891 | +27.2% | 0.03% | +3.7% |
| Q1 2022 | $237,000 | -2.5% | 43,932 | +144.5% | 0.03% | -3.6% |
| Q4 2021 | $243,000 | +6.6% | 17,965 | +41.7% | 0.03% | -3.4% |
| Q3 2021 | $228,000 | – | 12,675 | +66610.5% | 0.03% | – |
| Q1 2020 | $0 | -100.0% | 19 | -99.4% | 0.00% | -100.0% |
| Q4 2017 | $177,000 | – | 2,960 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |